ResMed Corporation: GLP-1 Demand Generation Strategy to Expand Customer Base & Strengthen Their Position!

ResMed Inc.’s Q3 Fiscal Year 2025 results reflected both robust performance and strategic plans poised for long term growth, giving investors a mixed but intriguing picture of the company’s current standing and future potential. The company reported strong financial results, with an 11% increase in non-GAAP net income and a 13% boost in diluted earnings per share, reaching $2.37. Revenue rose by 8% on a headline basis and 9% in constant currency terms, reflecting comprehensive growth across products and markets. Gross margin improved significantly by 140 basis points to 59.9%, thanks to efficiencies in manufacturing and distribution, favorable product mix, and a continued transition from the AirSense 10 to the AirSense 11 platform.